Prenatal exposure to flavonoids: Implication for cancer risk

Toxicological Sciences

Volumn 120, Issue 1, 2011, Pages 59-67

  Vanhees, Kimberly ^a   de Bock, Laura ^a   Godschalk, Roger W L ^a   van Schooten, Frederik J ^a   van Waalwijk van Doorn Khosrovani, Sahar Barjesteh ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atm gene; Genistein; In utero; Infant leukemia; Mll translocations; Quercetin

Indexed keywords

ATM PROTEIN; CLASTOGEN; FLAVONOID; GENISTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CANCER RISK; CONTROLLED STUDY; DIET; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; FETUS; GENE MUTATION; GENE REARRANGEMENT; GENE TARGETING; GENE TRANSLOCATION; GENOTOXICITY; HETEROZYGOTE; HOMOZYGOTE; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRENATAL EXPOSURE; TRANSPLACENTAL CARCINOGENESIS; WILD TYPE;

MUS;

EID: 79952074739     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq388     Document Type: Article

References (36)

1. Adlercreutz, H., Yamada, T., Wahala, K., and Watanabe, S. (1999). Maternal and neonatal phytoestrogens in Japanese women during birth. Am. J. Obstet. Gynecol. 180, 737-743.
2. Bakkenist, C. J., and Kastan, M. B. (2003). DNA damage activates AT through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506.
3. Barjesteh van Waalwijk van Doorn-Khosrovani, S., Janssen, J., Maas, L. M., Godschalk, R. W., Nijhuis, J. G., and van Schooten, F. J. (2007). Dietary flavonoids induce MLL translocations in primary human CD34+ cells. Carcinogenesis 28, 1703-1709.
4. Barlow, C, Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N, Ried, T., Tagle, D., et al. (1996). Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159-171.
5. Blanco, J. G., Edick, M. J., and Relling, M. V. (2004). Etoposide induces chimeric Mll gene fusions. FASEB J. 18, 173-175.
6. Felix, C. A. (1998). Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta 1400, 233-255.
7. Felix, C. A., and Lange, B. J. (1999). Leukemia in infants. Oncologist 4, 225-240.
8. Felix, C. A., Lange, B. J., Hosier, M. R., Fertala, J., and Bjornsti, M. A. (1995). Chromosome band 1 lq23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res. 55, 4287-4292.
9. Ferrali, M., Signorini, C, Caciotti, B., Sugherini, L., Ciccoli, L., Giachetti, D., and Comporti, M. (1997). Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett. 416, 123-129.
10. Ferry, D. R., Smith, A., Malkhandi, J., Fyfe, D. W., deTakats, P. G., Anderson, D., Baker, J., and Kerr, D. J. (1996). Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2, 659-668.
11. FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J., and Haber, D. A. (1997). Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat. Genet. 15, 307-310.
12. Formica, J. V., and Regelson, W. (1995). Review of the biology of Quercetin and related bioflavonoids. Food Chem. Toxicol. 33, 1061-1080.
13. Golding, S. E., Rosenberg, E., Khalil, A., McEwen, A., Holmes, M., Neill, S., Povirk, L. F., and Valerie, K. (2004). Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J. Biol. Chem. 279, 15402-15410.
14. Gumy-Pause, F., Wacker, P., and Sappino, A. P. (2004). ATM gene and lymphoid malignancies. Leukemia 18, 238-242.
15. Khanna, K. K. (2000). Cancer risk and the ATM gene: a continuing debate. J. Natl. Cancer Inst. 92, 795-802.
16. Libura, J., Slater, D. J., Felix, C. A., and Richardson, C. (2005). Therapy-related acute myeloid leukemia-like MLL rearrangements are induced by etoposide in primary human CD34+ cells and remain stable after clonal expansion. Blood 105, 2124-2131.
17. Libura, J., Ward, M., Solecka, J., and Richardson, C. (2008). Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential. Eur. J. Haematol. 81, 185-195.
18. Montecucco, A., and Biamonti, G. (2007). Cellular response to etoposide treatment. Cancer Lett. 252, 9-18.
19. Morton, M. S., Arisaka, O., Miyake, N., Morgan, L. D., and Evans, B. A. (2002). Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J. Nutr. 132, 3168-3171.
20. Oguchi, K., Takagi, M., Tsuchida, R., Taya, Y., Ito, E., Isoyama, K., Ishii, E., Zannini, L., Delia, D., and Mizutani, S. (2003). Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement. Blood 101, 3622-3627.
21. Record, I. R., Jannes, M., Dreosti, I. E., and King, R. A. (1995). Induction of micronucleus formation in mouse splenocytes by the soy isoflavone genistein in vitro but not in vivo. Food Chem. Toxicol. 33, 919-922.
22. Ross, J. A. (2000). Dietary flavonoids and the MLL gene: a pathway to infant leukemia? Proc. Natl. Acad. Sci. U.S.A. 97, 4411-4413.
23. Ross, J. A., and Kasum, C. M. (2002). Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 22, 19-34.
24. Ross, J. A., Potter, J. D., Reaman, G. H., Pendergrass, T. W., and Robison, L. L. (1996). Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 7, 581-590.
25. Schroder-van der Elst, J. P., van der Heide, D., Rokos, H., Morreale de Escobar, G., and Kohrle, J. (1998). Synthetic flavonoids cross the placenta in the rat and are found in fetal brain. Am. J. Physiol. 274, E253-E256.
26. Skibola, C. F., and Smith, M. T. (2000). Potential health impacts of excessive flavonoid intake. Free Radic. Biol. Med. 29, 375-383.
27. Spector, L. G., Xie, Y., Robison, L. L., Heerema, N. A., Hilden, J. M., Lange, B., Felix, C. A., Davies, S. M., Slavin, J., Potter, J. D., et al. (2005). Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol. Biomarkers Prev. 14, 651-655.
28. Spring, K., Ahangari, F., Scott, S. P., Waring, P., Purdie, D. M., Chen, P. C, Hourigan, K., Ramsay, J., McKinnon, P. J., Swift, M., et al. (2002). Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat. Genet. 32, 185-190.
29. Spring, K., Cross, S., Li, C, Watters, D., Ben-Senior, L., Waring, P., Ahangari, F., Lu, S. L., Chen, P., Misko, I., et al. (2001). Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res. 61, 4561-4568.
30. Stankovic, T., Stewart, G. S., Byrd, P., Fegan, C, Moss, P. A., and Taylor, A. M. (2002). ATM mutations in sporadic lymphoid tumours. Leuk. Lymphoma 43, 1563-1571.
31. Strick, R., Strissel, P. L., Borgers, S., Smith, S. L., and Rowley, J. D. (2000). Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. U.S.A. 97, 4790-4795.
32. Sung, P. A., Libura, J., and Richardson, C. (2006). Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions. DNA Repair (Amst.) 5, 1109-1118.
33. Todaka, E., Sakurai, K., Fukata, H., Miyagawa, H., Uzuki, M., Omori, M., Osada, H., Ikezuki, Y., Tsutsumi, O., Iguchi, T., et al. (2005). Fetal exposure to phytoestrogens-the difference in phytoestrogen status between mother and fetus. Environ. Res. 99, 195-203.
34. van Gent, D. C, Hoeijmakers, J. H., and Kanaar, R. (2001). Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2, 196-206.
35. Ye, R., Goodarzi, A. A., Kurz, E. U., Saito, S., Higashimoto, Y., Lavin, M. F., Appella, E., Anderson, C. W., and Lees-Miller, S. P. (2004). The isoflavonoids genistein and quercetin activate different stress signaling pathways as shown by analysis of site-specific phosphorylation of ATM, p53 and histone H2AX. DNA Repair (Amst.) 3, 235-244.
36. Zandvliet, D. W., Hanby, A. M., Austin, C. A., Marsh, K. L., Clark, I. B., Wright, N. A., and Poulsom, R. (1996). Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation. Biochim. Biophys. Acta 1307, 239-247.